Comprehensive Diagnostics with Deeper Insights

The rapid evolution of diseases and therapeutics is driving the need for comprehensive diagnostics with deeper insights. Healthcare providers must navigate an increasing demand for testing of complex diseases while also monitoring a broader range of conditions and patient populations.

These escalating demands challenge laboratories to establish advanced clinical capabilities which ensure clinical caregivers can best meet the needs of the patients they serve.

At Beckman Coulter Diagnostics, we recognize that every sample holds the potential to reveal even greater insights about the patient. As pioneers of innovative testing solutions, we are uncovering this information and advancing clinical capabilities around the world. We enable healthcare providers to make more-informed decisions with diagnostics that are accurate, sensitive, timely, accessible, and less invasive to improve patient care for better clinical outcomes.

Clinical Confidence

To make critical diagnostic decisions, you need highly precise and accurate test results. Empowered by rapid technological innovations and a growing test menu, our high-performance clinical diagnostics deliver reproducible, Six-Sigma-quality results that clinicians and patients can trust.

100% Sensitivity: Our Access HIV assay enables earlier diagnosis by detecting and differentiating HIV-1 p24 antigen and HIV-1/HIV-2 antibodies simultaneously and reporting antigen and antibody results separately. Learn More

Continued Assay Innovation: Beckman Coulter’s Alzheimer’s disease blood test, the p-Tau217/ß-AmyIoid 1-42 Plasma Ratio assay, has received FDA Breakthrough Device Designation (BDD). Learn More

Improved Efficiency

With fully automated testing capabilities and a growing and impactful assay menu that deliver high quality results with rapid turnaround, we’re ensuring clinicians receive more data to make effective, timely clinical decisions.

Reduced Time To First Result & Reduced Sample Volume: Technology breakthroughs in Beckman Coulter’s DxI 9000 analyzer enable a reduced time to the first result and can reduce the required sample volume.

Fastest Intraoperative PTH (ioPTH) Test Results: Performed while a patient is undergoing thyroid surgery when speed is critical, the DxI 9000 analyzer with Beckman Coulter’s Parathyroid Hormone assay can deliver accurate ioPTH results in as few as 8 minutes.

Eliminate Repeat Testing: Ready-to-use reagents and Beckman Coulter’s validated HBsAg High Positive algorithm streamline operations, eliminating the need for repeat testing for samples ≥ 100.00 S/CO.

clinical-capabilities-improved-efficiency

Collaborative Intelligence

Partnering with research and healthcare professionals, we are innovating at the speed of life. From discovery to RUO to post market IVD validations and updates, we are accelerating insights into biomarker identification and assay development—to ensure accuracy, quality, and utility worldwide, improving time to first results and speed to market.

Tackling Alzheimer’s Together: Biogen, Beckman Coulter, and Fujirebio are collaborating to identify and develop blood-based biomarkers for tau pathology in the brain and to potentially clinically advance and commercialize new tests for tau pathology in Alzheimer’s disease. Learn More

Bacterial or Viral Infection?: Beckman Coulter has partnered with MeMed to develop the Access MeMed BV Assay which is a regulatory-cleared host-immune response assay for accurately distinguishing between bacterial and viral infections within the ED workflow in just 15 minutes. Learn More

clinical-capabilities-collaborative-intelligence

Educational Resources

#2025-14380

Information addressed to health professionals. The products presented on this site are for professional use only, and, where applicable, comply with the requirements of the IVD Directive 98/79 / EC. Instructions for use must be consulted before using these products.

© 2025 Beckman Coulter, Inc. All rights reserved. Beckman Coulter, the stylized logo, and the Beckman Coulter product and service marks mentioned herein are trademarks or registered trademarks of Beckman Coulter, Inc. in the United States and other countries. All other trademarks are the property of their respective owners. Some products may not be available in your country or region. Please contact your Beckman Coulter sales representative or distributor for more information.

U.S. Government Users Restricted Rights - As per GSA ADP Schedule Contract with Beckman Coulter, Inc., the use, duplication or disclosure is restricted as follows: Beckman Coulter hereby authorizes user to copy those documents published on the World Wide Web by Beckman Coulter, for noncommercial use, and only within the user's organization. Except as expressly provided above, nothing contained herein shall be construed as granting any license or right under any Beckman Coulter copyright. Nothing contained herein shall be construed as granting by implication, estoppel or otherwise any license or right under any patent or trademark of Beckman Coulter or any third party.

Advancing Your Clinical Capabilities

Comprehensive Diagnostics with Deeper Insights

Clinical Confidence

Improved Efficiency

Collaborative Intelligence

Educational Resources

Highly Sensitive HIV Assay

High Sensitivity Troponin I Study

RUO Immunoassay for Alzheimer’s

Choose your country/region and language

Country or Region

Language

Advancing Your Clinical Capabilities

Comprehensive Diagnostics with Deeper Insights

Clinical Confidence

Improved Efficiency

Collaborative Intelligence

Educational Resources

Highly Sensitive HIV Assay

High Sensitivity Troponin I Study

RUO Immunoassay for Alzheimer’s